Health in Sur 315 indicators covering health for Sur. IndicatorLatest Year10-yr change Rank Hypertension treatment coverage among adults aged 30-79 with 49.2% 2019 up 11.1% 2nd Hypertension treatment coverage among adults aged 30-79 with 49.5% 2019 up 8.3% 2nd Hypertension: diagnosis coverage among adults aged 30-79 with 63.7% 2019 up 9.6% 2nd Hypertension among adults aged 30-79 years, prevalence, crude 42.8 2019 up 7.3% 1st Pneumococcal conjugate second or third-dose vaccines (PCVc) 0.0% 2025 — 2nd Number of new HIV infections 500 2025 unchanged 2nd Treatment success rate: previously treated TB cases 50 2023 up 150.0% 1st Medical doctors 13.07 2024 up 29.9% 2nd Adolescent birth rate 1.55 2022 down 36.6% 1st Reported number of people receiving antiretroviral therapy 4,070 2025 up 76.8% 1st Prevalence of insufficient physical activity among adults aged 18+ 48.7% 2022 up 15.9% 1st Prevalence of insufficient physical activity among adults aged 18+ 48.9% 2022 up 14.1% 1st Nursing and midwifery personnel 18.4 2024 down 6.0% 2nd TB patients with known HIV status 90.0% 2024 down 7.2% 2nd Number of people dying from HIV-related causes 500 2025 up 150.0% 2nd Confirmed cases of RR-/MDR-TB 11 2024 up 22.2% 1st Tested TB patients HIV-positive 18.0% 2024 down 37.9% 1st Births attended by skilled health personnel 100.0% 2021 up 11.1% 1st Number of new leprosy cases 14 2025 down 30.0% 1st New cases tested for RR-/MDR-TB 97.0% 2024 up 10.2% 2nd Age-standardized suicide rates 22.48 2021 down 11.9% 1st Number of deaths in children aged <5 years, by cause 50.78 2021 down 10.1% 2nd Premature deaths due to noncommunicable diseases (NCD) as a 55.56 2021 up 3.5% 1st Total NCD Deaths 2,592 2021 up 20.0% 2nd Probability (%) of dying between age 30 and exact age 70 from any of 18.7% 2021 down 5.6% 2nd Life expectancy at age 60 17.93 2021 down 14.4% 2nd Age-standardized NCD mortality rate 452.92 2021 down 10.8% 2nd Mortality rate attributed to unintentional poisoning 0.2084 2021 down 3.6% 2nd Life expectancy at birth 69.78 2021 down 4.6% 2nd Adult mortality rate (probability of dying between 15 and 60 years) 210.84 2021 up 26.8% 1st Previously treated cases tested for RR-/MDR-TB 62.0% 2024 down 23.5% 2nd Healthy life expectancy (HALE) at age 60 13.56 2021 down 14.6% 2nd nMx - age-specific death rate between ages x and x+n 0.0157 2021 down 23.6% 1st nLx - person-years lived between ages x and x+n 98,604 2021 up 0.4% 2nd lx - number of people left alive at age x 100,000 2021 unchanged 1st nqx - probability of dying between ages x and x+n 0.0155 2021 down 23.3% 1st Tx - person-years lived above age x 6.98 million 2021 down 4.6% 2nd Healthy life expectancy (HALE) at birth 60.3 2021 down 4.6% 2nd ex - expectation of life at age x 69.78 2021 down 4.6% 2nd ndx - number of people dying between ages x and x+n 1,552 2021 down 23.3% 1st Number of people notified with new episode of TB in a given year 93 2021 down 29.0% 1st Number of people diagnosed with new episode of pulmonary TB who are 9 2021 down 73.5% 1st Number of people diagnosed with new episode of pulmonary TB who have 7 2021 down 65.0% 1st Cases started on MDR-TB treatment 10 2024 — 1st Number of people diagnosed with new episode of pulmonary TB who are 72 2021 up 12.5% 2nd Raised fasting blood glucose (>=7.0 mmol/L) 12.3 2014 up 20.6% 2nd Mean fasting blood glucose (mmol/l) 5.63 2014 up 3.8% 2nd Raised fasting blood glucose (>= 7.0 mmol/L) 11.9 2014 up 32.2% 2nd Reported number of people requiring interventions against NTDs 233 2024 down 99.5% 2nd Percentage of total deaths due to NCDs overall and percentage of 14.09 2019 down 23.1% 2nd Inactivated first-dose polio vaccine (IPV1) immunization coverage 78.0% 2025 down 3.7% 2nd New leprosy case detection rate per 1 000 000 population 21.88 2025 down 40.6% 1st Reported number of children receiving antiretroviral therapy 22 2024 down 71.8% 2nd Low birth weight number 1.8 2020 up 5.9% 2nd Concentrations of fine particulate matter 9.99 2023 down 18.9% 1st New or unknown treatment history cases: Pulmonary, bacteriologically 85 2023 down 21.3% 2nd Leprosy registered prevalence rate per 1 000 000 population 21.88 2025 down 61.7% 1st Leprosy - Number of cases registered for treatment 14 2025 down 54.8% 1st Leprosy - Number of new leprosy cases among children 0 2025 down 100.0% 1st New leprosy child case detection rate (less than 15 years of age) per 0 2025 down 100.0% 1st ← Previous Page 3 of 6 Next →